Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 641066

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

perillyl alcohol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
PurposePerillyl alcohol (POH) is a naturally occurring lipid with preclinical activity against mammary carcinomas. We conducted a… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Highly Cited
2004
Highly Cited
2004
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer
Objective. We conducted a phase II multicenter trial of perillyl alcohol in patients with advanced hormone refractory prostate… Expand
Highly Cited
2000
Highly Cited
2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.
We conducted a phase I dose-escalation trial of perillyl alcohol (POH; NSC 641066) given p.o. on a continuous four times a day… Expand
2000
2000
Phase I Clinical and Pharmacokinetic Study of Perillyl Alcohol Administered Four Times a Day 1
We conducted a phase I dose-escalation trial of perillyl alcohol (POH; NSC 641066) given p.o. on a continuous four times a day… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2000
Highly Cited
2000
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Perillyl alcohol (POH) is a monoterpene with anticarcinogenic and antitumor activity in murine tumor models. Putative mechanisms… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE